Literature DB >> 15036671

Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.

Xavier Roumier1, Rahmene Azzouzi, Antoine Valéri, Francis Guillemin, Georges Fournier, Olivier Cussenot, Philippe Mangin, Luc Cormier.   

Abstract

OBJECTIVE: To assess the adherence to an annual PSA screening program conducted over 3 years in first-degree relatives of a sample of men with prostate cancer, and to identify characteristics of men who failed to undergo the full screening process. PATIENTS AND METHODS: Out of 747 candidates that were eligible for the screening program (asymptomatic brothers and sons aged between 40 and 70 years of men diagnosed with prostate cancer) 640 were contacted. The screening program entailed annual serum PSA testing over a 3-year period, during which every candidates attendance was recorded. At the outset, each candidate was requested to complete a questionnaire regarding their socio-professional characteristics, their level of anxiety and their attitude towards genetic susceptibility.
RESULTS: 442 (69%) candidates agreed to enter the study and 420 filled out the questionnaire. During the 3-year period, 50 candidates (12%) who had accepted the first year screening refused to undergo subsequent PSA tests. These men were younger ( p=0.015), more anxious (p=0.037 ) and to have more than one affected first-degree relative ( p=0.028 ).
CONCLUSIONS: The crucial and challenging step in the adherence to a screening program was the initial recruitment. Once recruited, adherence rate after 3 years was very high (88%). Identifying factors that help predict men who might leave the screening process may provide us means of improving their compliance in the future.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036671     DOI: 10.1016/j.eururo.2003.09.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

1.  Experiences of Uncertainty in Men With an Elevated PSA.

Authors:  Caitlin Biddle; Alicia Brasel; Willie Underwood; Heather Orom
Journal:  Am J Mens Health       Date:  2016-06-23

Review 2.  The role of anxiety in prostate carcinoma: a structured review of the literature.

Authors:  William Dale; Pinar Bilir; Misop Han; David Meltzer
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

3.  Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.

Authors:  Clement K Gwede; Stacy N Davis; Shaenelle Wilson; Mitul Patel; Susan T Vadaparampil; Cathy D Meade; Brian M Rivers; Daohai Yu; Javier Torres-Roca; Randy Heysek; Philippe E Spiess; Julio Pow-Sang; Paul Jacobsen
Journal:  Am J Health Promot       Date:  2014-06-26

4.  The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample.

Authors:  Ashwin A Kotwal; Phil Schumm; Supriya G Mohile; William Dale
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

5.  The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk.

Authors:  J Melia; D Dearnaley; S Moss; L Johns; P Coulson; C Moynihan; J Sweetman; M C Parkinson; R Eeles; M Watson
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

6.  Feasibility of familial PSA screening: psychosocial issues and screening adherence.

Authors:  J Sweetman; M Watson; A Norman; Z Bunstead; P Hopwood; J Melia; S Moss; R Eeles; D Dearnaley; C Moynihan
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

7.  Personality and gastric cancer screening attendance: a cross-sectional analysis from the Miyagi Cohort Study.

Authors:  Shizuha Arai; Naoki Nakaya; Masako Kakizaki; Kaori Ohmori-Matsuda; Taichi Shimazu; Shinichi Kuriyama; Akira Fukao; Ichiro Tsuji
Journal:  J Epidemiol       Date:  2009-01-22       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.